Foley Partner Andrew Rawlins was quoted in an article that appeared in BNA’s Medical Devices Law & Industry Report on February 9, 2011 titled “Senate Judiciary Committee Unanimously Approves Patent Reform Act of 2011.” Rawlins discusses a patent reform measure cleared by the Senate Judiciary Committee that would move the U.S. to a first-inventor-to-file system and make other changes to patent law, stating that the bill marks the fourth consecutive Congress in which comprehensive patent reform legislation has been introduced. He adds that there are significant interests on opposite sides of many of the issues proposed in the bill, which makes passage of the legislation seem difficult.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”